BVF PARTNERS L P/IL Insider Trading
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is a in Capstone Therapeutics Corp. ($CAPS) and a 10% Owner in CTI BIOPHARMA CORP ($CTIC) and a Director in CTI BIOPHARMA CORP ($CTIC) and a 10% Owner in XOMA Corp ($XOMA) and a Director in XOMA Corp ($XOMA) and a 10% Owner in ARQULE INC ($ARQL) and a 10% Owner in INFINITY PHARMACEUTICALS, INC. ($INFI) and a in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and a 10% Owner in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and a in CYTOKINETICS INC ($CYTK) and a 10% Owner in CYTOKINETICS INC ($CYTK) and a 10% Owner in GLYCOMIMETICS INC ($GLYC) and a 10% Owner in CONCERT PHARMACEUTICALS, INC. ($CNCE) and a 10% Owner in Syndax Pharmaceuticals Inc ($SNDX) and a in Eledon Pharmaceuticals, Inc. ($NVUS) and a in ChemoCentryx, Inc. ($CCXI) and a 10% Owner in ChemoCentryx, Inc. ($CCXI) and a 10% Owner in IMMUNE DESIGN CORP. ($IMDZ) and a 10% Owner in Calithera Biosciences, Inc. ($CALA) and a 10% Owner in Principia Biopharma Inc. ($PRNB) and a 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and a 10% Owner in Xenon Pharmaceuticals Inc. ($XENE) and a 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and a 10% Owner in Merus N.V. ($MRUS) and a in IDEAYA Biosciences, Inc. ($IDYA) and a 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and a Director in Rain Therapeutics Inc. ($RAIN) and a Director in Olema Pharmaceuticals, Inc. ($OLMA) and a Director in Kymera Therapeutics, Inc. ($KYMR).
Companies in which BVF PARTNERS L P/IL is an Insider
ALPINE IMMUNE SCIENCES, INC.
Trading Symbol: ALPNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 1,109,258 shares
Current Value: $2,595,664
Latest Transaction: Jun 22 2017
$ALPN Market Capitalization: $36.22M
$ALPN Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARQULE INC
Trading Symbol: ARQLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 4,682,669 shares
Current Value: $6,415,257
Latest Transaction: Jun 01 2018
$ARQL Market Capitalization: $96.01M
$ARQL Previous Close: $1.37
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Calithera Biosciences, Inc.
Trading Symbol: CALAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 3,712,340 shares
Current Value: $33,782,294
Latest Transaction: May 26 2020
$CALA Market Capitalization: $187.67M
$CALA Previous Close: $9.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Capstone Therapeutics Corp.
Trading Symbol: CAPSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL:
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 18 2017
$CAPS Market Capitalization: $3.48M
$CAPS Previous Close: $0.09
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ChemoCentryx, Inc.
Trading Symbol: CCXIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL:
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 05 2015
$CCXI Market Capitalization: $309.30M
$CCXI Previous Close: $6.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CONCERT PHARMACEUTICALS, INC.
Trading Symbol: CNCEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 1,178,904 shares
Current Value: $10,551,191
Latest Transaction: Jun 12 2019
$CNCE Market Capitalization: $197.12M
$CNCE Previous Close: $8.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CTI BIOPHARMA CORP
Trading Symbol: CTICIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: Director, 10% Owner
Holdings: 4,085,933 shares
Current Value: $19,081,307
Latest Transaction: Apr 05 2021
$CTIC Market Capitalization: $129.36M
$CTIC Previous Close: $4.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CYTOKINETICS INC
Trading Symbol: CYTKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL:
Holdings: 3,811,271 shares
Current Value: $44,591,871
Latest Transaction: Dec 11 2020
$CYTK Market Capitalization: $461.88M
$CYTK Previous Close: $11.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Eledon Pharmaceuticals, Inc.
Trading Symbol: ELDNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL:
Holdings: 117,565 shares
Current Value: $106,984
Latest Transaction: Dec 28 2020
$ELDN Market Capitalization: $20.25M
$ELDN Previous Close: $0.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
FIVE PRIME THERAPEUTICS, INC.
Trading Symbol: FPRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL:
Holdings: 670,695 shares
Current Value: $30,436,139
Latest Transaction: Nov 13 2020
$FPRX Market Capitalization: $1.23B
$FPRX Previous Close: $45.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GLYCOMIMETICS INC
Trading Symbol: GLYCIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 4,306,320 shares
Current Value: $26,957,563
Latest Transaction: Nov 03 2020
$GLYC Market Capitalization: $140.70M
$GLYC Previous Close: $6.26
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IDEAYA Biosciences, Inc.
Trading Symbol: IDYAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL:
Holdings: 1,642,186 shares
Latest Transaction: Feb 04 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IMMUNE DESIGN CORP.
Trading Symbol: IMDZIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 2,502,758 shares
Current Value: $13,264,617
Latest Transaction: Dec 04 2018
$IMDZ Market Capitalization: $132.13M
$IMDZ Previous Close: $5.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INFINITY PHARMACEUTICALS, INC.
Trading Symbol: INFIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 5,663,912 shares
Current Value: $13,310,193
Latest Transaction: Jan 26 2021
$INFI Market Capitalization: $115.87M
$INFI Previous Close: $2.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kymera Therapeutics, Inc.
Trading Symbol: KYMRIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BVF PARTNERS L P/IL: Director
Holdings: 837,916 shares
Latest Transaction: Aug 25 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Merus N.V.
Trading Symbol: MRUSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 3,803,152 shares
Current Value: $91,161,553
Latest Transaction: Apr 01 2021
$MRUS Market Capitalization: $388.15M
$MRUS Previous Close: $23.97
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Olema Pharmaceuticals, Inc.
Trading Symbol: OLMAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: Director
Holdings: 99,556 shares
Latest Transaction: May 26 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PIERIS PHARMACEUTICALS, INC.
Trading Symbol: PIRSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 2,385,055 shares
Current Value: $5,247,121
Latest Transaction: Sep 10 2019
$PIRS Market Capitalization: $91.71M
$PIRS Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Principia Biopharma Inc.
Trading Symbol: PRNBIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 0 shares
Latest Transaction: Aug 20 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Rain Therapeutics Inc.
Trading Symbol: RAINIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: Director
Holdings: 761,537 shares
Latest Transaction: May 17 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Syndax Pharmaceuticals Inc
Trading Symbol: SNDXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 498,025 shares
Current Value: $4,327,837
Latest Transaction: Jun 20 2018
$SNDX Market Capitalization: $163.37M
$SNDX Previous Close: $8.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Xenon Pharmaceuticals Inc.
Trading Symbol: XENEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 336,468 shares
Current Value: $2,759,038
Latest Transaction: Mar 29 2018
$XENE Market Capitalization: $145.83M
$XENE Previous Close: $8.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
XOMA Corp
Trading Symbol: XOMAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: Director, 10% Owner
Holdings: 200,000 shares
Current Value: $842,000
Latest Transaction: Dec 15 2020
$XOMA Market Capitalization: $25.10M
$XOMA Previous Close: $4.21
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of BVF PARTNERS L P/IL
Sentiment: All, ALPN, ARQL, CALA, CAPS, CCXI, CNCE, CTIC, CYTK, ELDN, FPRX, GLYC, IDYA, IMDZ, INFI, KYMR, MRUS, OLMA, PIRS, PRNB, RAIN, SNDX, XENE, XOMA
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 26 2021 | OLMA | Olema Pharmaceutic ... | BVF PARTNERS L P/IL | Director | Buy | J | 0.00 | 99,556 | 0 | 99,556 | 0 to 99.6 K |
May 17 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | P | 14.26 | 3,474 | 49,544 | 91,700 | 88.2 K to 91.7 K (+3.94 %) |
May 17 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | P | 14.26 | 22,721 | 324,036 | 555,105 | 532.4 K to 555.1 K (+4.27 %) |
May 17 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | P | 14.26 | 31,805 | 453,587 | 761,537 | 729.7 K to 761.5 K (+4.36 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 134,515 | 0 | 0 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 152,176 | 0 | 0 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 17,390 | 0 | 152,176 |